Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1140520

registered interest
date	19/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Fish: Hygiene and Safety
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the safety and food hygiene rules for the transport of smoked fish (a) within and (b) to the UK is governed by (i) UK or (ii) EU regulations.
tabling member constituency	Cardiff Central
tabling member printed	Jo Stevens
uin	279407
answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>The longstanding rules governing the transport of food of animal origin, including smoked fish are provided by European Union food safety and hygiene regulations which apply directly to the United Kingdom. This legislation lays down effective and proportionate food safety and hygiene controls throughout the food chain, from primary production to sale or supply to the food consumer. In England, The Food Safety and Hygiene (England) Regulations 2013 provides for the enforcement of certain provisions of EU food safety hygiene legislation. It also provides national law for certain elements including temperature control in retail establishments. Parallel legislation applies in Scotland, Wales and Northern Ireland.</p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 26/07/2019 11:42:59 answering member 4455 label Biography information for Seema Kennedy previous answer version 131082 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
tabling member	4425 label Biography information for Jo Stevens

1140530

registered interest
date	19/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Preventive Medicine
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will publish the prevention Green Paper before the summer recess.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	279415
answer	answer is ministerial correction date of answer 24/07/2019 answer text <p>The Green Paper ‘Advancing our health: prevention in the 2020s’ was published on 22 July 2019.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 24/07/2019 06:37:56 answering member 4455 label Biography information for Seema Kennedy
tabling member	4056 label Biography information for Nic Dakin

1140540

registered interest
date	19/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Clinical Commissioning Groups: North East
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential effect on public engagement in the NHS of the proposed merger of five clinical commissioning groups in the North East.
tabling member constituency	Easington
tabling member printed	Grahame Morris
uin	279425
answer	answer is ministerial correction date of answer 25/07/2019 answer text <p>The clinical commissioning groups (CCGs) are currently looking at different options as to how they can work together in the future to consolidate their current collaborative working arrangements. The emerging preferred option from the public, member, staff, partner and stakeholder engagement so far, is a single CCG in Durham, which would be co-terminus with the local authority and a single CCG in the Tees Valley (covering the Tees Combined Authority area) with a shared management arrangement.</p><p>The CCGs in Durham have been working together for some time with joint appointments since 2014 and ‘in-common’ meetings since May 2017. NHS Durham Dales, Easington and Sedgefield CCG and NHS North Durham CCG also have a shared lay member for patient and public participation.</p><p>Should the CCGs decide to progress the merger application at the end of August, a Communication and Engagement Strategy, which is currently in development, will be submitted with the application.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 25/07/2019 14:28:03 answering member 1585 label Biography information for Stephen Hammond previous answer version 131081 answering member constituency Wimbledon answering member printed Stephen Hammond answering member 1585 label Biography information for Stephen Hammond
tabling member	3973 label Biography information for Grahame Morris

1140542

registered interest
date	19/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Clinical Commissioning Groups
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the merits of the change from primary care trusts to clinical commissioning groups for the NHS.
tabling member constituency	Easington
tabling member printed	Grahame Morris
uin	279427
answer	answer is ministerial correction date of answer 25/07/2019 answer text <p>On 1 April 2013, clinical commissioning groups (CCGs) replaced primary care trusts (PCTs) as the primary commissioner of National Health Service services in England.</p><p>Unlike PCTs, CCGs are clinically led, and so are better able to use clinical expertise to assess and prioritise those treatments that provide the safest and most effective outcomes for their population. The evidence suggests that general practitioner-led CCGs have allowed the redesign of patient pathways and local services based on clinical evidence, and a more effective dialogue and partnership with other parts of the health system.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 25/07/2019 14:26:05 answering member 1585 label Biography information for Stephen Hammond previous answer version 131080 answering member constituency Wimbledon answering member printed Stephen Hammond answering member 1585 label Biography information for Stephen Hammond
tabling member	3973 label Biography information for Grahame Morris

1140557

registered interest
date	19/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Kawasaki Disease: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an estimate of (a) the potential cost savings of improving early identification and treatment of Kawasaki disease and (b) the potential consequent reduction in demand for long-term specialist care for children with that disease.
tabling member constituency	Cardiff West
tabling member printed	Kevin Brennan
uin	279381
answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>The requested information is not available and therefore no such estimate has been made.</p><p>NHS Improvement has previously published a Patient Safety Alert for the attention of providers of National Health Service-funded care to emphasise the high risk and atypical presentation of coronary artery aneurysms, coronary thrombosis and myocardial ischaemia or infarction in patients with Kawasaki disease, and to highlight the importance of specialist advice.</p><p>Guidance is also available from the National Institute for Health and Care Excellence (NICE) on the assessment and initial management of fever in children under five, and this guidance includes recommendations on recognising the symptoms of Kawasaki disease.</p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 26/07/2019 11:40:10 answering member 4455 label Biography information for Seema Kennedy previous answer version 131089 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
tabling member	1400 label Biography information for Kevin Brennan

1140558

registered interest
date	19/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Kawasaki Disease: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what support his Department is providing to (a) enable early treatment and (b) increase awareness amongst healthcare providers of Kawasaki disease .
tabling member constituency	Cardiff West
tabling member printed	Kevin Brennan
uin	279382
answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>NHS Improvement has previously published a Patient Safety Alert for the attention of providers of National Health Service-funded care to emphasise the high risk and atypical presentation of coronary artery aneurysms, coronary thrombosis and myocardial ischaemia or infarction in patients with Kawasaki disease, and to highlight the importance of specialist advice.</p><p>Guidance is also available from the National Institute for Health and Care Excellence (NICE) on the assessment and initial management of fever in children under five, and this guidance includes recommendations on recognising the symptoms of Kawasaki disease.</p><p>NICE’s clinical guidelines help healthcare professionals deliver the best possible care based on the best available evidence; the guidelines are not mandatory, although health and care commissioners are expected to take them fully into account.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 26/07/2019 11:37:42 answering member 4455 label Biography information for Seema Kennedy previous answer version 131090 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
tabling member	1400 label Biography information for Kevin Brennan

1140559

registered interest
date	19/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Kawasaki Disease: Medical Records
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of establishing a patient registry on Kawasaki disease.
tabling member constituency	Cardiff West
tabling member printed	Kevin Brennan
uin	279383
answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>No such assessment has been made.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 26/07/2019 11:41:26 answering member 4455 label Biography information for Seema Kennedy previous answer version 131091 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
tabling member	1400 label Biography information for Kevin Brennan

1140560

registered interest
date	19/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Kawasaki Disease: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent comparative assessment he has made of the UK level of research funding into Kawasaki disease with that of other EU member states.
tabling member constituency	Cardiff West
tabling member printed	Kevin Brennan
uin	279384
answer	answer is ministerial correction date of answer 25/07/2019 answer text <p>The Department has not made a recent comparative assessment of the United Kingdom level of research funding into Kawasaki disease with that of other European Union member states.</p><p> </p><p>The EU has recently agreed to fund a Kawasaki disease study led from Great Ormond Street Hospital/University College London. The trial, which aims to recruit 262 children from 40 centres across Europe, will look at the effectiveness of using of steroids in addition to the standard treatment for Kawasaki syndrome, intravenous immunoglobulins. The award is for over €5 million in funding for the trial to be run through a new European consortium, connect4children.</p><p> </p><p>The National Institute for Health Research (NIHR) Imperial Biomedical Research Centre was funded between 2013-18 to carry out a project on the ‘Genetic determinants of Kawasaki disease for susceptibility and outcome’ with NIHR funding of £77,000.</p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 25/07/2019 14:19:10 answering member 4008 label Biography information for Dame Caroline Dinenage previous answer version 131092 answering member constituency Gosport answering member printed Caroline Dinenage answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1400 label Biography information for Kevin Brennan

1140582

registered interest
date	19/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to issue guidance to health professionals on the Serious Shortage Protocol.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	279389
answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>A Serious Shortage Protocol is an additional tool to manage serious medication shortages and may be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.</p><p>At present we are currently working on the governance process for developing Serious Shortage Protocols, should one be required, through engagement, including with professional bodies and patient groups. Following this we will issue guidance to health professionals in due course.</p><p>The Pharmaceutical Services Negotiating Committee, the organisation who represent National Health Service community pharmacy contractors in England, have developed a briefing note to support community pharmacies, who will need to consider training and changes to their standard operating-procedures to take account of the potential new processes.</p><p>Any Serious Shortage Protocol would be developed by senior, specialist doctors and pharmacists, with input from national experts, Royal Colleges and specialist societies. If a Serious Shortage Protocol is to be authorised then there will also be engagement with the relevant patient groups, who can assist in informing patients. Pharmacists still have to use their professional judgment as to whether supplying against the protocol rather than the prescription is appropriate and provide the patient with relevant information. If they determine supply is not appropriate, then the patient should be referred back to their prescriber.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 26/07/2019 11:34:54 answering member 4455 label Biography information for Seema Kennedy previous answer version 131086 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
tabling member	1439 label Biography information for Norman Lamb

1140584

registered interest
date	19/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans the Government has provide information to patients on changes to the provision of medicines as a result of the serious shortage protocol; and if he will make a statement.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	279390
answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>A Serious Shortage Protocol is an additional tool to manage serious medication shortages and may be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.</p><p>At present we are currently working on the governance process for developing Serious Shortage Protocols, should one be required, through engagement, including with professional bodies and patient groups. Following this we will issue guidance to health professionals in due course.</p><p>The Pharmaceutical Services Negotiating Committee, the organisation who represent National Health Service community pharmacy contractors in England, have developed a briefing note to support community pharmacies, who will need to consider training and changes to their standard operating-procedures to take account of the potential new processes.</p><p>Any Serious Shortage Protocol would be developed by senior, specialist doctors and pharmacists, with input from national experts, Royal Colleges and specialist societies. If a Serious Shortage Protocol is to be authorised then there will also be engagement with the relevant patient groups, who can assist in informing patients. Pharmacists still have to use their professional judgment as to whether supplying against the protocol rather than the prescription is appropriate and provide the patient with relevant information. If they determine supply is not appropriate, then the patient should be referred back to their prescriber.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 279391 question first answered 26/07/2019 11:36:12 answering member 4455 label Biography information for Seema Kennedy previous answer version 131087 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
tabling member	1439 label Biography information for Norman Lamb